Researchers working in a mice reported that an experimental drug, NTRX-07, may treat Alzheimer’s by targeting a potential cause — it was seen to ease brain inflammation in the animals by restoring the brain’s ability to remove clumps of the beta-amyloid protein that is a hallmark of the disease. The excessive…
News
Low-calorie diets are a known benefit for the overall health of the body, but the exact mechanisms underlying this effect remain elusive. Now, a study published in the journal Aging Cell, has shown that low-calorie intake increases neurons’ capacity to neutralize excessive levels of calcium, which contribute to neuronal damage…
Alzheimer’s-related Tau Protein as Potential New Biomarker for Teens with Early-onset Psychosis
Tau, a protein already linked to Alzheimer’s disease, can be traced in greater concentrations in the blood plasma levels of under-age children with early onset psychosis (EOP), according to a recent study. The study was included at this year’s International Early Psychosis Association (IEPA) meeting Oct. 20-22 in Milan,…
Roobirk and Antidote, two startup companies that work to empower people living with Alzheimer’s disease have entered a partnership with Galaxy, an online portal to initiatives that facilitate patient participation in Alzheimer’s research. More than 80% of clinical studies overall are delayed or closed because not enough patients meet enrollment requirements.
A treatment that uses microscopic droplets of fat – called nanoliposomes – to carry drugs to the brain has  been used effectively to target cancer cells. Now the technique has shown promise in restoring memory loss in mice models of Alzheimer’s disease, according to a new study funded by the Alzheimer’s…
Most National Alzheimer’s Project Studies Not Looking to Show Clinical Benefit, Scientists Argue
Two physicians — one at the University of Pennsylvania’s Perelman School of Medicine and the other with the University of Michigan — argue in a recent opinion piece that the National Alzheimer Project Act (NAPA), as it now stands, has resulted in potential treatments for Alzheimer’s disease being tested without a…
A technique using light intensity to detect explosive residue in homemade bombs, also known as improvised explosive devices (IEDs), is now being used by researchers from the University of Adelaide in South Australia to identify vitamins in blood that are linked to Alzheimer’s disease and dementia. Vitamin B12 is…
Using laser technology, researchers have found that peptides related to Alzheimer’s Disease move at dangerous speeds prior to clumping or forming the plaques that characterize the disease. Moreover, the scientists also identified strategies to keep the blocks that form the proteins moving at safe speeds. The study, “Monomer Dynamics…
Researchers reviewed the novel mutations found in genes associated with early-onset Alzheimer’s disease in Asian countries, arguing that identifying disease-associated mutations greatly contributes to the knowledge of the cause and effect of the disease. This information is also essential to develop preventive and therapeutic strategies. The study, “Mutations, Associated With Early-Onset Alzheimer’s Disease, Discovered In…
Cure Alzheimer’s Fund, a Massachusetts-based nonprofit dedicated to funding promising research into ways to prevent, slow, or reverse Alzheimer’s disease, has awarded more than $700,000 in research grants in September to scientists working toward those goals. The five newly funded projects brings Cure Alzheimer’s research support for 2016 to more…
Recent Posts
- FDA designation may speed new treatment for Alzheimer’s psychosis August 3, 2026
- Study reports Alzheimer’s treatment gains in long-term care July 6, 2026
- Awareness month event has new name: Do What You Love to End Alzheimer’s June 1, 2026
- FDA approves Auvelity to treat Alzheimer’s-related agitation May 4, 2026
- Daily Alzheimer’s pill slows brain shrinkage, boosts cognition April 6, 2026